Skip to main content

Day: July 14, 2023

Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering

Written by Customer Service on . Posted in Public Companies.

BERKELEY, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the pricing of an upsized underwritten public offering of 19,230,769 shares of its common stock at a public offering price of $6.50 per share. All of the common stock to be sold in the offering will be offered by Caribou. The gross proceeds to Caribou from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $125 million, excluding any exercise of the underwriters’ option. Caribou has granted the underwriters a 30-day option to purchase up to an additional 2,884,615 shares of its common stock at the public offering price per share, less underwriting discounts and commissions. The...

Continue reading

Vitamin C Market to Worth USD 6.27 Billion by 2030 | Skyquest Technology

Written by Customer Service on . Posted in Mergers And Acquisitions.

Vitamin C market is segmented based on source, application, process and product type. Based on source, the global market is segmented into natural and synthetic. Based on application, the global market is segmented into food & beverages, pharmaceuticals, cosmetics and animal feed. The market is segmented by process into the Reichstein process, a two-stage fermentation process. By product type, the market is segmented into powder, tablets, capsules, gummies, and liquids- Industry Forecast 2023-2030 Westford, USA, July 13, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the global vitamin C market is projected to experience significant growth due to the rising utilization of vitamin C in various food products and as a dietary supplement. Vitamin C, also known as ascorbic acid, is essential in preventing different types of heart...

Continue reading

Sagimet Biosciences Announces Pricing of Upsized Initial Public Offering

Written by Customer Service on . Posted in Public Companies.

SAN MATEO, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced the pricing of its upsized initial public offering of 5,312,500 shares of its Series A common stock at a public offering price of $16.00 per share. All of the shares of Series A common stock are being offered by Sagimet. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sagimet, are expected to be $85.0 million. Sagimet’s Series A common stock is expected to begin trading on the Nasdaq Global Market on July 14, 2023 under the ticker symbol “SGMT.” The offering is expected to close on July 18, 2023, subject to the...

Continue reading

Madison Pacific Properties Inc. announces the results for the nine months ended May 31, 2023 and declares dividend

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, July 13, 2023 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces the results of operations for the nine months ended May 31, 2023. The results reported are pursuant to International Financial Reporting Standards (IFRS) for public companies. For the nine months ended May 31, 2023, the Company is reporting net income of $26.2 million (2022: $37.3 million); cash flows from operating activities before changes in non-cash operating balances of $8.2 million (2022: $7.4 million); and income per share of $0.43 (2022: $0.60). Included in net income is a net gain on the fair value adjustment on investment properties of approximately $13.4 million (2022: $21.6 million). The Company currently owns approximately $695 million in investment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.